Closing the HPV Testing Gap Act
Bill Summary
Requires health insurance to cover testing for the human papillomavirus (HPV) in certain cases, helping to detect related cancers earlier. Funds education and outreach to raise awareness about HPV and its connection to cancer.
Sponsored By
Bill Journey
- May 20, 2026
- May 20, 2026You Are Here
The committee will review the bill, debate amendments, and vote on whether to advance it to the full chamber.
- TBD
The full chamber debates the bill, may amend it, and votes on whether to pass it.
- TBD
If passed by the first chamber, the other chamber considers, may amend, and votes on the bill.
- TBD
If passed by both chambers, the bill goes to the President to sign into law or veto.
Why It Matters
This bill affects individuals at risk for HPV-related cancers, particularly women and people with certain health conditions, by increasing their access to preventive testing and care. It also impacts healthcare providers and insurers by mandating coverage for HPV testing and related services.
Impact Areas
Support & Opposition
- Democratic1
Documents
1
Full text opens on congress.gov, the official source.
Bill Details
Summary and impact analysis written by Judy (KnowGov's enrichment AI). Bill metadata, status, sponsor, and any floor votes from Prism. Sections marked “Sample” are placeholders not yet connected to live data.
